SynthesisCardiovascular diabetology2025

Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis.

Arveen Shokravi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.